Published in Brain Res on May 04, 1998
The blood-brain barrier: bottleneck in brain drug development. NeuroRx (2005) 5.45
Progress and problems in the application of focused ultrasound for blood-brain barrier disruption. Ultrasonics (2008) 1.42
PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model. Brain Res (2008) 1.11
Noninvasive and targeted drug delivery to the brain using focused ultrasound. ACS Chem Neurosci (2013) 0.95
Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin. J Neurooncol (2009) 0.95
Nanoscale drug delivery systems and the blood-brain barrier. Int J Nanomedicine (2014) 0.94
Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability. J Clin Invest (2002) 0.91
Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model. Mol Cancer (2007) 0.89
Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (RMP-7): dramatic differences and insight gained from dosing parameters. Br J Cancer (1999) 0.88
Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models. Brain Res (2008) 0.85
Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib. World J Surg Oncol (2012) 0.85
Drug delivery across the blood-brain barrier using focused ultrasound. Expert Opin Drug Deliv (2014) 0.84
Focused ultrasound-mediated drug delivery through the blood-brain barrier. Expert Rev Neurother (2015) 0.84
Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood-brain barrier. Int J Nanomedicine (2014) 0.79
Pharmacological modulation of cytotoxicity and cellular uptake of anti-cancer drugs by PDE5 inhibitors in lung cancer cells. Pharm Res (2013) 0.78
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier. Curr Pharm Des (2016) 0.76
The complete nucleotide sequence of the tobacco chloroplast genome: its gene organization and expression. EMBO J (1986) 19.59
Murine CD1d-restricted T cell recognition of cellular lipids. Immunity (2000) 3.57
Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci U S A (1996) 2.67
Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med (2000) 2.30
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann Oncol (2008) 2.29
A putative gene of tobacco chloroplast coding for ribosomal protein similar to E. coli ribosomal protein S19. Nucleic Acids Res (1983) 2.26
MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity (2001) 2.19
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res (2001) 2.11
Do anger and aggression affect carotid atherosclerosis? Stroke (1993) 1.96
Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med (1990) 1.85
Genes for the eight ribosomal proteins are clustered on the chloroplast genome of tobacco (Nicotiana tabacum): similarity to the S10 and spc operons of Escherichia coli. Proc Natl Acad Sci U S A (1986) 1.83
Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg (1991) 1.81
Complete nucleotide sequence of the chloroplast genome from the green alga Chlorella vulgaris: the existence of genes possibly involved in chloroplast division. Proc Natl Acad Sci U S A (1997) 1.75
Glioblastoma induction after radiosurgery for meningioma. Lancet (2000) 1.67
STAT6 deficiency in a mouse model of allergen-induced airways inflammation abolishes eosinophilia but induces infiltration of CD8+ T cells. Clin Exp Allergy (1999) 1.64
The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity (1998) 1.59
Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab (1988) 1.59
Evolution and mechanism of translation in chloroplasts. Annu Rev Genet (1998) 1.50
Rhythmic Cl- current and physiological roles of the intestinal c-kit-positive cells. Pflugers Arch (1995) 1.49
Kinetics of apoptosis in the lung of mice with allergic airway inflammation. Clin Exp Allergy (1998) 1.47
Clonal V alpha 12.1+ T cell expansions in the peripheral blood of rheumatoid arthritis patients. J Exp Med (1993) 1.47
Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. Eur J Immunol (2000) 1.43
Possible predictive markers of immunotherapy in esophageal cancer: retrospective analysis of a randomized study. The Cooperative Study Group for Esophageal Cancer in Japan. Cancer Invest (1995) 1.42
Cerebral edema induced by arachidonic acid: role of leukocytes and 5-lipoxygenase products. Neurosurgery (1989) 1.42
The CD1 family of lipid antigen-presenting molecules. Immunol Today (1998) 1.42
Mitochondrial encephalomyopathy with elderly onset of stroke-like episodes. Intern Med (1996) 1.39
Increased urinary beta 2-microglobulin in cadmium exposure: dose-effect relationship and biological significance of beta 2-microglobulin. Environ Health Perspect (1979) 1.37
Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy. Proc Natl Acad Sci U S A (1996) 1.30
cDNA structure, expression and nucleic acid-binding properties of three RNA-binding proteins in tobacco: occurrence of tissue-specific alternative splicing. Nucleic Acids Res (1993) 1.22
Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer. Br J Cancer (2005) 1.21
Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Jpn J Ophthalmol (1999) 1.20
Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Cancer Res (2001) 1.20
Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. Brain Res Mol Brain Res (1994) 1.20
Relationship between Glasgow coma scale and functional outcome. Am J Phys Med Rehabil (1996) 1.16
Preliminary experience with MR-guided thermal ablation of brain tumors. AJNR Am J Neuroradiol (1995) 1.16
Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report. Neurosurg Focus (2000) 1.16
Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer (2001) 1.15
Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery (1996) 1.15
DLK1: increased expression in gliomas and associated with oncogenic activities. Oncogene (2006) 1.15
Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase. Biochim Biophys Acta (1975) 1.15
Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. J Neurosurg (1999) 1.12
Chloroplast RNA-binding and pentatricopeptide repeat proteins. Biochem Soc Trans (2004) 1.10
Isolation of tumour stem-like cells from benign tumours. Br J Cancer (2009) 1.10
Expression of different combinations of interleukins by human T cell leukemic cell lines that are clonally related. J Exp Med (1989) 1.09
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme. Oncogene (2012) 1.08
The protective effects of dietary fish oil on focal cerebral infarction. Prostaglandins Med (1979) 1.08
Ceramidase deficiency in Farber's disease (lipogranulomatosis). Science (1972) 1.08
Use of B-mode ultrasound for visceral fat mass evaluation: comparisons with magnetic resonance imaging. Appl Human Sci (1995) 1.05
Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy. Exp Neurol (1996) 1.04
A model of cell size regulation. J Theor Biol (1965) 1.04
Dual targeting of phage-type RNA polymerase to both mitochondria and plastids is due to alternative translation initiation in single transcripts. Biochem Biophys Res Commun (2001) 1.01
Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. Brain Res (1994) 1.01
MRI of thermally denatured blood: methemoglobin formation and relaxation effects. Magn Reson Imaging (1999) 1.00
Identification of 10Sa RNA (tmRNA) homologues from the cyanobacterium Synechococcus sp. strain PCC6301 and related organisms. Biochim Biophys Acta (1998) 1.00
Leukotrienes increase blood-brain barrier permeability following intraparenchymal injections in rats. Ann Neurol (1985) 1.00
Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia. J Cereb Blood Flow Metab (1997) 1.00
Gene expression abnormalities in human glial tumors identified by gene array. Int J Oncol (2001) 1.00
Chloroplast ribonucleoproteins are associated with both mRNAs and intron-containing precursor tRNAs. FEBS Lett (1999) 1.00
Chloroplast ribonucleoproteins function as a stabilizing factor of ribosome-free mRNAs in the stroma. J Biol Chem (2001) 1.00
Ulinastatin ameliorates acute ischemic renal injury in rats. Ren Fail (1996) 0.99
Blood-brain barrier and new approaches to brain drug delivery. West J Med (1992) 0.99
Parkinsonism after acute cadmium poisoning. Clin Neurol Neurosurg (1997) 0.98
Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. J Cereb Blood Flow Metab (1994) 0.98
MAP4 is the in vivo substrate for CDC2 kinase in HeLa cells: identification of an M-phase specific and a cell cycle-independent phosphorylation site in MAP4. Biochemistry (1997) 0.98
Three types of nuclear genes encoding chloroplast RNA-binding proteins (cp29, cp31 and cp33) are present in Arabidopsis thaliana: presence of cp31 in chloroplasts and its homologue in nuclei/cytoplasms. Plant Mol Biol (1995) 0.98
GFR per nephron and per kidney in chronically diseased (pyelonephritic) kidney of the rat. Am J Physiol (1969) 0.97
Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease. Curr Eye Res (2001) 0.97
Transcript analysis of the tobacco plastid operon rps2/atpI/H/F/A reveals the existence of a non-consensus type II (NCII) promoter upstream of the atpI coding sequence. Mol Gen Genet (1998) 0.97
Treatment of Vogt-Koyanagi- Harada's disease during pregnancy. Jpn J Ophthalmol (2001) 0.96
Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors. J Neurosurg (1994) 0.96
Comparison of clinical features and survival in patients with hepatitis B and C virus-related hepatocellular carcinoma. Jpn J Clin Oncol (1997) 0.96
Differential expression of CCAAT enhancer binding protein family in rat alveolar epithelial cell proliferation and in acute lung injury. Cell Tissue Res (1999) 0.96
Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res (1996) 0.95
Correlation between bradykinin-induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors. Neurol Res (2001) 0.94
Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol (1997) 0.94
Recurrent episcleritis associated with adult T cell leukaemia. Br J Ophthalmol (1993) 0.93
Prostate cancer-induced oncogenic hypophosphatemic osteomalacia. Urol Int (1995) 0.93
[An experience of video-assisted thoracoscopic surgery for an intrapulmonary needle under CT-guided marking]. Kyobu Geka (1998) 0.92
Intra-arterial carboplatin chemotherapy for brain tumors: a dose escalation study based on cerebral blood flow. J Neurooncol (1997) 0.92
Physical and gene maps of the unicellular cyanobacterium Synechococcus sp. strain PCC6301 genome. Plant Mol Biol (1996) 0.91
Aspergillus species strain M39 produces two naphtho-gamma-pyrones that reverse drug resistance in human KB cells. Int J Cancer (1990) 0.90
Biological response and subjective symptoms in low level lead exposure. Arch Environ Health (1974) 0.90
Extraction of human Langerhans cells: a method for isolation of epidermis-resident dendritic cells. J Immunol Methods (2001) 0.90
Neuronal expression of mint1 and mint2, novel multimodular proteins, in adult murine brain. Brain Res Mol Brain Res (2001) 0.90
Characterization of a cDNA encoding a novel type of RNA-binding protein in tobacco: its expression and nucleic acid-binding properties. Mol Gen Genet (1994) 0.90
Impairment of transalveolar fluid transport and lung Na(+)-K(+)-ATPase function by hypoxia in rats. J Appl Physiol (1985) (1999) 0.90
The role of tumor necrosis factor-alpha in the induction of experimental autoimmune uveoretinitis in mice. Invest Ophthalmol Vis Sci (1994) 0.89
In vivo osmoregulation of Na/myo-inositol cotransporter mRNA in rat kidney medulla. J Am Soc Nephrol (1994) 0.89
Ultrastructural localization of mint1 at synapses in mouse hippocampus. Eur J Neurosci (2000) 0.89
Marked, sustained expression of a novel 150-kDa oxygen-regulated stress protein, in severely ischemic mouse neurons. Brain Res Mol Brain Res (1998) 0.89
Slowly progressive limb-kinetic apraxia with a decrease in unilateral cerebral blood flow. Acta Neurol Scand (1992) 0.89
A novel small stable RNA, 6Sa RNA, from the cyanobacterium Synechococcus sp. strain PCC6301. FEBS Lett (1997) 0.89
Preoperative evaluation and surgical management of the Arnold-Chiari II malformation. J Neurosurg (1986) 0.89
Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Cooperative Study Group for Esophageal Cancer in Japan. Am J Clin Oncol (1995) 0.89
Alterations of Bcl-2 family proteins precede cytoskeletal proteolysis in the penumbra, but not in infarct centres following focal cerebral ischemia in mice. Neuroscience (1998) 0.88
Heme oxygenase-1 (HO-1) protein induction in a mouse model of asthma. Clin Exp Allergy (2001) 0.88
Trans retinoic acid inhibits in vivo tumour growth of C6 glioma in rats: effect negatively influenced by nerve growth factor. Neurol Res (1994) 0.88
Influence of Mycobacterium bovis bacillus Calmette Guérin on in vitro induction of CD1 molecules in human adherent mononuclear cells. Infect Immun (2001) 0.88
Iris neovascularization after vitrectomy combined with phacoemulsification and intraocular lens implantation for proliferative diabetic retinopathy. Ophthalmic Surg Lasers (2001) 0.88
Amyloid precursor protein associates independently and collaboratively with PTB and PDZ domains of mint on vesicles and at cell membrane. Neuroscience (2001) 0.88